Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label cancer costs. Show all posts
Showing posts with label cancer costs. Show all posts
Saturday, May 19, 2012

paywalled: Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis [Original Contributions]

›
Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis [Original Contributions] : Purpose: Oral ...
Saturday, April 14, 2012

Higher US expenditures on cancer patients do not result in improved mortality. : denialism blog

›
Higher US expenditures on cancer patients do not result in improved mortality. : denialism blog                                     ~~~~~~...
Saturday, March 17, 2012

JCO abstract: Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care

›
 Blogger's Note : semantics - 'most'/'majority' requires language editing eg. majority 68%, most 59% (language bias?) ...
Thursday, January 26, 2012

US Oncologists Confront Pressure to Curb Cancer Costs - OncologySTAT

›
Saturday, May 28, 2011

abstract: Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer

›
CONCLUSIONS: Combined weekly cDC ( concurrent docetaxel and carboplatin ) appeared to be cost-effective compared with sDC ( sequential ...
Wednesday, April 13, 2011

The cost of drugs: breaking the bank to stay alive - The Globe and Mail

›
Wednesday, April 06, 2011

blog: Taking a Stab at Cost-Effectiveness | Work In Progress

›
"....With an aim toward making some small step forward in that direction, Cohn et al tried analyzing the cost-effectiveness of Avasti...
Monday, March 07, 2011

abstract JCO: At What Cost Does a Potential Survival Advantage of Bevacizumab Make Sense for the Primary Treatment of Ovarian Cancer? A Cost-Effectiveness Analysis

›
Abstract Purpose   To determine whether the addition of bevacizumab to paclitaxel and carboplatin for the primary treatment of advanced ovar...

Ohio State study: Targeted ovarian cancer therapy not cost-effective (Bevacizumab/Avastin)

›
Note : read the whole article  ------------------------------------------------------------------------------------ Ohio State study: Targ...
Friday, January 14, 2011

Cancer Prevalence and Cost of Care Projections - Interactive Guide NCI (via WSJ link)

›
Key Facts 18.1 million cancer survivors in 2020, 30% more than 2010 Costs of cancer care: $157 billion in 2010 dollars Growth and agi...

Cancer-Care Costs Could Hit $207 Billion in 2020: NCI Study - Health Blog - WSJ

›
"....Statistical modeling, of course, depends on the assumptions used by the researchers — so check out the full study to see those de...

Projections of the Cost of Cancer Care in the United States: 2010–2020 — J. Natl. Cancer Inst.

›
excerpt/also see Table 5 for projection (cost) estimates: Recent and Projected Incidence For most of the cancer sites, incidence has ...
Saturday, December 18, 2010

The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review

›
CONCLUSION: Ultimately, serial imaging and the CA-125 assay detected the highest number of ovarian cancer and PCC progressive disease cas...
Tuesday, October 19, 2010

Comments | Decisions at the end of life: have we come of age? full free access - open for commentary

›
Decisions at the end of life: have we come of age? Linda Emanuel and Karen Glasser Scandrett BMC Medicine 2010, 8 : 57 doi:10....
Tuesday, September 07, 2010

Perspective: Can We Treat Cancer for a Dollar a Day? Guidelines for Low-Income Countries — NEJM

›
Wednesday, August 18, 2010

The American Cancer Society And LIVESTRONG(R) Launch First Global Economic Cost Of Cancer Report

›
Monday, August 16, 2010

Understanding Patient Perspectives on Communication About the Cost of Cancer Care: A Review of the Literature — JOP

›
Conclusion: To my knowledge, patient preferences surrounding discussion of cost of cancer care have gone largely unstudied and are thus unk...